Market Place
Sourcing Support
Avicanna Reports Q3 2024
14 Nov 2024 //
GLOBENEWSWIRE
Avicanna Announces Closing of Non-Brokered Private Placement
04 Nov 2024 //
GLOBENEWSWIRE
Avicanna Announces Medical Cannabis Real World Evidence Study
23 Sep 2024 //
GLOBENEWSWIRE
Avicanna Announces Repayment of Debentures
30 Aug 2024 //
GLOBENEWSWIRE
Avicanna Announces Closing of Non-Brokered Private Placement
28 Aug 2024 //
GLOBENEWSWIRE
Avicanna Announces US Patent Issuance On Topical Technology
27 Aug 2024 //
GLOBENEWSWIRE
Avicanna Subsidiary Completes Export of Aureus Branded CBG into Denmark
15 Aug 2024 //
GLOBENEWSWIRE
Avicanna Reports Q2 2024
14 Aug 2024 //
GLOBENEWSWIRE
Avicanna Announces Changes of Auditors
02 Aug 2024 //
GLOBENEWSWIRE
Avicanna Subsidiary Completes Export of Aureus Branded CBG into Singapore
11 Jul 2024 //
GLOBENEWSWIRE
Avicanna Announces Results of Annual General Meeting & Provides Corporate Update
10 Jul 2024 //
GLOBENEWSWIRE
Avicanna Announces USPTO Patent Issuance For SEDDS Technology
19 Jun 2024 //
GLOBENEWSWIRE
Avicanna Announces General Meeting
19 Jun 2024 //
GLOBENEWSWIRE
Avicanna To Present At Life Science Investor Forum June 20, 2024
18 Jun 2024 //
GLOBENEWSWIRE
Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter
14 May 2024 //
GLOBENEWSWIRE
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
13 May 2024 //
GLOBENEWSWIRE
Avicanna Announces Closing of Non-brokered Private Placement
18 Apr 2024 //
GLOBENEWSWIRE
Avicanna Completes Topical Gel Observational Study
10 Apr 2024 //
GLOBENEWSWIRE
Avicanna Reports Full Year 2023 Audited Financial Results
02 Apr 2024 //
GLOBENEWSWIRE
Avicanna Announces the Canadian Launch of 10% CBD Proprietary Formulation
27 Mar 2024 //
GLOBENEWSWIRE
Avicanna To Hold Full Year 2023 Earnings Conference Call
26 Mar 2024 //
GLOBENEWSWIRE
Avicanna Hosts Symposium on Cannabinoid-based Medicine
29 Feb 2024 //
GLOBENEWSWIRE
Avicanna Announces New Research Collaboration with Pharmaceutical Company
15 Feb 2024 //
GLOBENEWSWIRE
Avicanna Obtains Its First Indication-Specific Drug Registration with Trunerox
13 Feb 2024 //
GLOBENEWSWIRE
Avicanna Announces Supply and Licensing Agreement with Pharma Company
05 Feb 2024 //
GLOBENEWSWIRE
Avicanna & Ease Labs Granted Commercialization Approval for Pharma Preparation
30 Jan 2024 //
GLOBENEWSWIRE
Avicanna Announces Closing of Non-Brokered Private Placement
04 Dec 2023 //
GLOBENEWSWIRE
Avicanna Reports Q3 2023 Results
14 Nov 2023 //
GLOBENEWSWIRE
Avicanna Announces Appointment of Paul Fornazzari to Board of Directors
13 Nov 2023 //
GLOBENEWSWIRE
Avicanna To Hold Third Quarter 2023 Earnings Conference Call
01 Nov 2023 //
GLOBENEWSWIRE
Avicanna Provides Update on the Successful Launch of MyMedi.ca
11 Oct 2023 //
GLOBENEWSWIRE
Retirement of Chandra Panchal, PhD from the Board of Directors
01 Sep 2023 //
GLOBENEWSWIRE
Avicanna Reports Q2 2023 Financial Statement
15 Aug 2023 //
GLOBENEWSWIRE
Avicanna Announces Closing of Non-Brokered Private Placement of Debenture Units
02 Aug 2023 //
GLOBENEWSWIRE
Avicanna Announces Closing of Acquisition and Launch of MyMedi.ca
01 Aug 2023 //
GLOBENEWSWIRE
Avicanna is Pleased to Announce the Initial Network of Brands on the MyMedi.ca
28 Jul 2023 //
GLOBENEWSWIRE
Avicanna Subsidiary SMGH Exports Aureus Branded CBD and CBG Into Paraguay
17 Jul 2023 //
GLOBENEWSWIRE
Avicanna Provides Corporate Update and Preliminary Q2 Results
28 Jun 2023 //
GLOBENEWSWIRE
Avicanna and Medipharm Labs Expand Strategic Manufacturing Agreement
26 Jun 2023 //
GLOBENEWSWIRE
Avicanna and Langara College Announce Research Collaboration and NSERC Grant
13 Jun 2023 //
GLOBENEWSWIRE
Avicanna Announces Results of Annual General and Special Meeting
17 May 2023 //
GLOBENEWSWIRE
Avicanna Reports Q1 2023 Financial Statement
16 May 2023 //
GLOBENEWSWIRE
Avicanna & Northern Green Canada Execute Master Service Agreement
04 May 2023 //
GLOBENEWSWIRE
Avicanna Announces Closing of Non-Brokered Private Placement
21 Mar 2023 //
GLOBENEWSWIRE
Avicanna Expands its Partnership with Viola Brands to the United Kingdom
07 Feb 2023 //
GLOBENEWSWIRE
Avicanna Announces Warrant and Debenture Repricing and Amendments
30 Jan 2023 //
GLOBENEWSWIRE
Santa Marta Completes First Commercial Export of feminized Cannabis Seeds
17 Jan 2023 //
GLOBENEWSWIRE
Avicanna Announces Organizational Change in Avicanna LATAM S.A.S
30 Dec 2022 //
GLOBENEWSWIRE
Avicanna Announces Organizational Change in Avicanna LATAM S.A.S
30 Dec 2022 //
GLOBENEWSWIRE
Avicanna Announces Promotion of Phillip Cardella to Chief Financial Office
21 Dec 2022 //
GLOBENEWSWIRE
Avicanna and Santé Cannabis Initiate Real-World Study on Musculoskeletal Pain
14 Dec 2022 //
GLOBENEWSWIRE
Avicanna Commercializes ‘Influid’ in the Canadian Market
29 Nov 2022 //
GLOBENEWSWIRE
Avicanna Announces Extension of Term Loan
31 Oct 2022 //
GLOBENEWSWIRE
Avicanna Files Patent Specifications Relating to Novel Cannabinoid Formulation
20 Oct 2022 //
GLOBENEWSWIRE
Avicanna Introduces a New Medical Cannabis Education Online Portal
18 Oct 2022 //
GLOBENEWSWIRE
Avicanna Expands its Epilepsy Research Program with a New Collaboration
15 Sep 2022 //
GLOBENEWSWIRE
Avicanna Reports Q2 2022 Financial Statement
15 Aug 2022 //
GLOBENEWSWIRE
Avicanna and Ei. Ventures Enter into an Agreement for Adaptogen Nutraceuticals
20 Jul 2022 //
GLOBENEWSWIRE
Avicanna Announces Date of Upcoming Annual General and Special Meeting
11 Jul 2022 //
GLOBENEWSWIRE
Avicanna Completes its First Commercial Export of its Derma-Cosmetics Brand
07 Jul 2022 //
GLOBENEWSWIRE
